Follicle Stimulating Hormone Market Size Share Growth

The Follicle Stimulating Hormone Global Market Report 2023, provides comprehensive information on the follicle stimulating hormone market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Follicle Stimulating Hormone Market’s Growth:

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

As per The Business Research Company’s Follicle Stimulating Hormone Global Market Report 2023, the global follicle stimulating hormone market is expected to grow from $1.83 billion in 2022 to $1.94 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The follicle stimulating hormone market is expected to reach $2.36 billion in 2027 at a CAGR of 5%.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12486&type=smp

Product innovations are a key trend gaining popularity in the follicle-stimulating hormone market. Major companies operating in the follicle-stimulating hormone market are focused on developing innovative products to strengthen their position in the market. For instance, in August 2021, Merck Specialties Pvt. Ltd., an India-based healthcare company, introduced the Pergoveris Pen, aiming to enhance infertility treatment options in the country. The Pergoveris Pen is an innovative device that combines recombinant follicle-stimulating hormone (FSH) and recombinant luteinizing hormone (LH) in a convenient, pre-filled format. It is the first to combine these hormones within a pen injector. Designed for prescribed use by IVF specialists, the Pergoveris Pen offers a combination treatment solution specifically for women experiencing severe deficiencies in follicle stimulating hormone (FSH) and luteinizing hormone (LH).

The follicle stimulating hormone market is segmented:

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

North America was the largest region in the follicle stimulating hormone market in 2022.

The table of contents in TBRC’s follicle stimulating hormone market report includes:

1. Executive Summary
2. Follicle Stimulating Hormone Market Characteristics
3. Follicle Stimulating Hormone Market Trends And Strategies
4. Follicle Stimulating Hormone Market – Macro Economic Scenario
5. Global Follicle Stimulating Hormone Market Size and Growth

.

.

.

32. Global Follicle Stimulating Hormone Market Competitive Benchmarking
33. Global Follicle Stimulating Hormone Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market
35. Follicle Stimulating Hormone Market Future Outlook and Potential Analysis
36. Appendix

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model